Last updated on September 2018

Study of ISIS 703802 in Subjects With Hypertriglyceridemia Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease


Brief description of study

This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 703802 and to assess the efficacy of different doses and dosing regimens of ISIS 703802 on glucose and lipid metabolism, and liver fat in subjects with Hypertriglyceridemia, Type 2 Diabetes Mellitus (T2DM), and Nonalcoholic Fatty Liver Disease (NAFLD).

Clinical Study Identifier: NCT03371355

Find a site near you

Start Over

Clinical Site

Hamilton, ON Canada
  Connect »

Clinical Site

Phoenix, AZ United States
  Connect »

Clinical Site

Montclair, CA United States
  Connect »

Clinical Site

Jupiter, FL United States
  Connect »

Clinical Site

Port Saint Lucie, FL United States
  Connect »

Clinical Site

Chicago, IL United States
  Connect »

Clinical Site

Cincinnati, OH United States
  Connect »

Clinical Site

Los Angeles, CA United States
  Connect »

Clinical Site

Boca Raton, FL United States
  Connect »

Clinical Site

Atlanta, GA United States
  Connect »

Clinical Site

Louisville, KY United States
  Connect »

Clinical Site

Austin, TX United States
  Connect »

Clinical Site

Huntington Park, CA United States
  Connect »

Clinical Site

Charleston, SC United States
  Connect »

Clinical Site

Panorama City, CA United States
  Connect »

Clinical Site

Hurst, TX United States
  Connect »

Clinical Site

Toronto, ON Canada
  Connect »

Clinical Site

San Antonio, TX United States
  Connect »

Clinical Site

Chicoutimi, QC Canada
  Connect »

Clinical Site

Carrollton, TX United States
  Connect »

Clinical Site

Greensboro, NC United States
  Connect »

Clinical Site

High Point, NC United States
  Connect »

Clinical Sites

Chandler, AZ United States
  Connect »

Clinical Site

Fountain Hills, AZ United States
  Connect »

Clinical Site

Glendale, AZ United States
  Connect »

Clinical Site

Mesa, AZ United States
  Connect »

Clinical Site

Edina, MN United States
  Connect »

Clinical Site

Dallas, TX United States
  Connect »

Clinical Site

Layton, UT United States
  Connect »

Clinical Site

Bridgeton, NJ United States
  Connect »

Clinical Site

Montréal, QC Canada
  Connect »